Skip to content
Screener

Abbott ABT Q1 2025 earnings

Reported April 16, 2025 · Before market open

Revenue$10.4BMiss by $48.0M
EPS$1.09Beat by $0.02
Revenue estimate$10.4B
EPS estimate$1.07

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$13.0B
EPS estimate$1.42

Financials

Q1 2025

Income statement

See full
Revenue$10.4B+4.0%
Gross profit$5.9B+7.1%
Operating income$1.7B+22.2%
Net income$1.3B+8.2%
EPS (diluted)$0.76+8.6%

Balance sheet

See full
Cash & equivalents$6.5B+3.9%
Total debt$13.2B-9.2%
Total equity$48.8B+25.8%
Total assets$81.4B+12.4%

Cash flow

See full
Operating cash flow$1.4B+38.2%
CapEx$484.0M+21.6%
Free cash flow$933.0M+48.8%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$230.06B+16.6%
Enterprise value$236.77B+15.2%
P/E17×-18.0×
P/S5.4×+0.5×

Profitability

See full
Gross margin55.8%+0.7pp
Operating margin16.8%+1.1pp
Net margin31.9%+17.9pp
FCF margin15.7%+3.5pp

Returns & leverage

See full
Return on equity30.8%+16.0pp
Debt / equity0.3×-0.1×
Current ratio1.8×+0.2×

Segments

By geography

See full
United States$4.2B—
Germany$689.8M—
China$476.8M—
India$467.8M—
Switzerland$467.8M—

By segment

See full
Medical Devices$4.9B+9.9%
Nutritional Products$2.1B+3.8%
Diagnostic Products$2.1B-7.2%
Established Pharmaceuticals$1.3B+2.8%

FAQ

When did Abbott report Q1 2025 earnings?
Abbott (ABT) reported Q1 2025 earnings on April 16, 2025 before market open.
What were Abbott's Q1 2025 revenue and EPS?
Abbott reported revenue of $10.4B and eps of $1.09 for Q1 2025.
Did Abbott beat estimates in Q1 2025?
Revenue missed the consensus estimate of $10.4B by $48.0M. EPS beat the consensus estimate of $1.07 by $0.02.
Where can I find Abbott's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-017924) and the 10-Q periodic report (0001628280-25-021090) directly on SEC EDGAR. The filing index links above go to sec.gov.